Benjamin R Lee, MD, internationally known for his expertise in kidney cancer surgery, prostate cancer and calculus treatment and innovations, is chief of the Division of Urology in the University of Arizona College of Medicine –Tucson Department of Surgery, and Director of the Genitourinary Cancer and Disease oriented strategic planning team at the University of Arizona Cancer Center.
Dr. Lee joins the UA after serving as a Professor of Urology at Tulane University School of Medicine in New Orleans where he was director of the robotic, laparoscopy and endourology fellowship. Dr. Lee is noted for developing novel techniques for robotic and laparoscopic surgery, and is also a leading authority on robotic treatment of Renal Cell Carcinoma and Prostate cancer, as well as nanotechnology applications in Urologic Oncology.
Dr. Lee graduated from Cornell University magna cum laude. He then attended the Johns Hopkins School of Medicine, and continued at the James Buchanan Brady Urological Institute at Johns Hopkins for residency with Dr. Patrick Walsh and Dr. Alan Partin, learning the art of laparoscopy under Dr. Lou Kavoussi. He joined the faculty at North Shore Long Island Jewish Medical Center, and developed expertise in treatment of stone disease with the founder of Endourology, Dr. Arthur Smith. While at Tulane University he published on nanotechnology applications to improve drug delivery for treatment of renal cell carcinoma; methods to decrease the morbidity of surgery; identifying methods of decreasing recurrence of cancer; explanations why the immune system may be activated differently following laparoscopy compared to open surgery, and further studies focused on preserving kidney function during laparoscopic & robotic kidney surgery.
Dr. Lee’s research has been recognized by awards from the American Urological Association, The Endourological Society and Urology Journal. He was awarded the prestigious Arthur Smith Award in 2008 for his contributions to the discipline of robotics, laparoscopy, and minimally invasive surgery. He was Organizing Secretary of the 31st World Congress of Endourology which was held in New Orleans, LA in 2013. He has served on the Board of Directors for the SES - American Urological Association, currently on the Finance committee for the Endourological Society Editorial board for the Journal of Endourology, and Co-editor of the Journal of Endourology Case Reports. He previously was Chair of the American Urological Association Task Force on e-learning development for AUA University.
Dr. Lee has focused his career on advancing new treatments for renal cell carcinoma as well as developing new technologies & techniques for Urologic Oncology. He has participated in many national and international clinical research trials. He is author or co-author of more than 250 manuscripts, book chapters and educational teaching videos. He was instrumental in developing a multidisciplinary nanotechnology research program which included integration of Urology, Biomedical Engineering, Biomolecular engineering, Pathology, and Physics and Materials Engineering.